Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tomblyn

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Bone Marrow Transplantation|March 26, 2014
Comparison of 1-day vs 2-day dosing of high-dose melphalan followed by autologous hematopoietic cell transplantation in patients with multiple myelomaS R Parmar, R Bookout, J F Shapiro, et al.
Bone Marrow Transplantation|September 23, 2008
Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphomaV Bachanova, C G Brunstein, L J Burns, et al.
Bone Marrow Transplantation|October 29, 2009
Regionally limited or rare infections: prevention after hematopoietic cell transplantationJ Gea-Banacloche, H Masur, C Arns da Cunha, et al.
Bone Marrow Transplantation|January 20, 2009
Comparison of two mycophenolate mofetil dosing regimens after hematopoietic cell transplantationP Jacobson, S F El-Massah, J Rogosheske, et al.
Bone Marrow Transplantation|September 3, 2013
Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remissionG Kunter, J B Perkins, J Pidala, et al.
Bone Marrow Transplantation|August 7, 2012
Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilizationJ Pidala, J Kim, M Schell, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 3, 2012
No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantationM Tomblyn, M Chen, M Kukreja, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Bone Marrow Transplantation|March 26, 2014
Comparison of 1-day vs 2-day dosing of high-dose melphalan followed by autologous hematopoietic cell transplantation in patients with multiple myelomaS R Parmar, R Bookout, J F Shapiro, et al.
Bone Marrow Transplantation|September 23, 2008
Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphomaV Bachanova, C G Brunstein, L J Burns, et al.
Bone Marrow Transplantation|October 29, 2009
Regionally limited or rare infections: prevention after hematopoietic cell transplantationJ Gea-Banacloche, H Masur, C Arns da Cunha, et al.
Bone Marrow Transplantation|January 20, 2009
Comparison of two mycophenolate mofetil dosing regimens after hematopoietic cell transplantationP Jacobson, S F El-Massah, J Rogosheske, et al.
Bone Marrow Transplantation|September 3, 2013
Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remissionG Kunter, J B Perkins, J Pidala, et al.
Bone Marrow Transplantation|August 7, 2012
Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilizationJ Pidala, J Kim, M Schell, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 3, 2012
No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantationM Tomblyn, M Chen, M Kukreja, et al.
Pageof 2